Published in Lab Law Weekly, February 2nd, 2007
Phoqus has undertaken an early stage formulation development project for GSK using its proprietary modified release technology, Qtrol. The objectives of the pharmacokinetic study are to determine the release profile and bioavailability of the drug from the formulation.
GSK has financed the development of the formulation and manufacture of clinical supplies by Phoqus, and is conducting the pharmacokinetic study....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.